Stay updated on Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The record history now shows the latest revision as v3.6.3, indicating the page was updated. The previous revision v3.6.1 is removed from the history view.
    Difference
    0.1%
    Check dated 2026-07-02T14:25:13.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.1) has been added to the Study Record History, superseding the prior revision (v3.6.0). This reflects an updated release of the study record on the ClinicalTrials.gov history page.
    Difference
    0.1%
    Check dated 2026-06-25T12:45:25.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The record now shows that recruitment has ended with a banner stating 'No longer looking for participants'. A new revision tag v3.6.0 was added, replacing the previous v3.5.5.
    Difference
    0.5%
    Check dated 2026-06-10T04:52:24.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page shows a newer system revision label (v3.5.5) replacing the previous v3.5.4, indicating an internal update to the study record history interface.
    Difference
    0.1%
    Check dated 2026-06-02T23:01:02.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    New revision v3.5.4 appears in the study's history. The previous revision v3.5.3 is removed from the list.
    Difference
    0.1%
    Check dated 2026-05-19T15:47:18.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.3) was added to the study's record history, reflecting an update to the record since the previous version.
    Difference
    0.2%
    Check dated 2026-04-28T07:50:20.000Z thumbnail image

Stay in the know with updates to Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.